290 related articles for article (PubMed ID: 1489487)
1. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
DeAizpurua HJ; Honeyman MC; Harrison LC
J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
[TBL] [Abstract][Full Text] [Related]
2. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
De Aizpurua HJ; Wilson YM; Harrison LC
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709
[TBL] [Abstract][Full Text] [Related]
3. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
4. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.
Harrison LC; De Aizpurua H; Loudovaris T; Campbell IL; Cebon JS; Tait BD; Colman PG
Diabetes; 1991 Sep; 40(9):1128-33. PubMed ID: 1936620
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
6. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR
Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
[TBL] [Abstract][Full Text] [Related]
8. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM.
Diaz JL; Ways J; Hammonds P
Diabetes; 1992 Jan; 41(1):118-21. PubMed ID: 1727731
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
13. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
[TBL] [Abstract][Full Text] [Related]
14. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
[TBL] [Abstract][Full Text] [Related]
17. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
[TBL] [Abstract][Full Text] [Related]
18. Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.
Trigwell SM; Radford PM; Page SR; Loweth AC; James RF; Morgan NG; Todd I
Clin Exp Immunol; 2001 Nov; 126(2):242-9. PubMed ID: 11703367
[TBL] [Abstract][Full Text] [Related]
19. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
Björk E; Velloso LA; Kämpe O; Karlsson FA
Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
[TBL] [Abstract][Full Text] [Related]
20. T-cell responses to autoantigens in IDDM. The search for the Holy Grail.
Roep BO
Diabetes; 1996 Sep; 45(9):1147-56. PubMed ID: 8772714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
